A case series is a type of medical study that describes a group of patients who share a similar diagnosis or received similar treatment. It contains no comparison group, which makes it one of the simpler study designs in medicine, but also one of the most common ways new diseases, rare side effects, and unusual treatment responses first get documented.
How a Case Series Works
A case series collects detailed information about multiple patients with something in common. That shared thread might be a particular disease, an unusual complication, or a specific treatment. For each patient, the authors typically report demographics like age and sex, the diagnosis, what treatment was given, how the patient responded, and what happened during follow-up. Think of it as several patient stories told together so that patterns can emerge.
The key distinction from a case report is simply the number of patients. A case report describes one patient. Once you group multiple patients together, it becomes a case series. There’s no universally agreed-upon minimum number, but most journals treat anything beyond a single patient as a series. Some series include five or ten patients; others include hundreds. The defining feature isn’t the size but the structure: a collection of similar cases described without a control or comparison group.
Why Case Series Matter
Case series punch above their weight when it comes to spotting things no one has noticed before. They can identify new diseases or new trends in known diseases, detect previously unrecognized drug side effects, and document rare manifestations that larger studies would never be designed to find. Early in the HIV/AIDS epidemic, for example, case series describing clusters of unusual pneumonia and rare cancers in young men were what first signaled a new disease to the medical community.
They also serve an educational purpose. Clinicians reading a well-written case series learn from another team’s experience, picking up practical lessons about diagnosis or management that wouldn’t fit into the rigid format of a clinical trial. For rare conditions where large studies are impractical or impossible, a case series may be the best available evidence for years.
Where Case Series Rank as Evidence
In the standard evidence pyramid used in evidence-based medicine, case series sit near the bottom. The pyramid ranks study designs by their internal validity, meaning how well they protect against bias. At the top are systematic reviews and meta-analyses, followed by randomized controlled trials, then cohort studies and case-control studies. Case series and case reports occupy the lower tiers, just above basic science research.
The reason is straightforward: without a comparison group, a case series can’t tell you whether the treatment actually caused the outcome you’re seeing. If 15 patients with a rash improve after taking a new cream, it looks promising. But without knowing how 15 similar patients would have done without the cream, you can’t rule out the possibility that the rash would have resolved on its own. Case series can explore and suggest, but they cannot confirm or prove.
Key Limitations
Beyond the lack of a comparison group, case series have several other weaknesses worth understanding:
- Selection bias. The patients included are rarely chosen at random. A surgeon might report their best outcomes or their most dramatic cases, which skews the picture.
- Limited generalizability. A small group of patients at one hospital may not represent patients elsewhere with different demographics, resources, or disease severity.
- Alternative explanations. Any apparent cause-and-effect relationship in a case series could have other explanations, from coincidence to confounding factors the authors didn’t measure.
- Reporting bias. Case series that show striking or unusual results are more likely to get published, which can distort how common or effective something appears.
These limitations don’t make case series useless. They make case series a starting point. The typical path in medicine is for a case series to generate a hypothesis that then gets tested in a controlled study with a comparison group.
How Case Series Get Published
For surgical case series, authors follow a standardized reporting checklist called PROCESS (Preferred Reporting Of Case Series in Surgery), most recently updated in 2023. This checklist ensures that published series include enough detail about patient selection, outcomes, and follow-up for readers to judge the quality of the evidence. Other fields use similar frameworks to keep reporting transparent and consistent.
The ethical and regulatory requirements depend on the size and nature of the series. A single case report at many institutions can be published without formal review board approval, as long as patient-identifying information is removed or the patient gives written consent. Once you combine multiple cases into a series, though, many institutions require institutional review board (IRB) approval because the work is now considered human subjects research. Patient privacy rules still apply either way. Authors who strip out all identifying details, including unique characteristics that could make someone recognizable, generally don’t need signed consent. Authors who include any identifying information need the patient’s written authorization.
Case Series vs. Other Study Types
Understanding where a case series fits relative to other designs helps you evaluate medical information you encounter online or in the news.
- Case report: Describes a single patient. Even less generalizable than a case series, but useful for documenting something truly novel.
- Case series: Describes multiple patients with no comparison group. Good for spotting patterns. Cannot establish cause and effect.
- Cohort study: Follows a group of patients over time and compares those exposed to something with those who weren’t. Much stronger for identifying risk factors.
- Randomized controlled trial: Randomly assigns patients to a treatment or a placebo. The gold standard for testing whether a treatment works.
When you see a headline claiming a treatment “cured” a group of patients, check whether the underlying study is a case series. If it is, the results are worth noting but far from definitive. The treatment still needs to be tested against a comparison group before anyone can confidently say it works.